SLE-key® rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP®

Chaim Putterman, Alan Wu, Anat Reiner-Benaim, D. Scott Batty, Ignacio Sanz, Jim Oates, Keren Jakobi, Michelle Petri, Pennina Safer, Robert Gerwien, Rachel Sorek, Yakov Blumenstein, Irun R. Cohen

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

We describe here the development, verification and validation of the SLE-key® rule-out test for a definitive rule-out of a diagnosis of systemic lupus erythematosus (SLE). The test uses the proprietary iCHIP® micro-array technology platform (Fattal et al., 2010) to identify discriminating patterns of circulating autoantibodies among SLE patients compared with self-declared healthy individuals. Given the challenges associated with the diagnosis of SLE and the healthcare costs of delayed diagnosis and misdiagnosis, a definitive rule-out test can provide significant clinical benefits to patients and potentially major cost savings to healthcare systems.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalJournal of Immunological Methods
Volume429
DOIs
StatePublished - Feb 1 2016

Keywords

  • Autoantibodies
  • Diagnosis
  • ICHIP
  • Microarray
  • Multivariate classifier
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'SLE-key® rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP®'. Together they form a unique fingerprint.

Cite this